The use of poly ADP-ribose polymerase 1 (PARP1) has been very common in the treatment of breast cancer and ovarian cancer, and its role may be to prevent the repair of fatal single strand breaks and double strand breaks in some genetic backgrounds. This evidence concerns the gene PARP1 and ovarian carcinoma.